STOCK TITAN

Leonardo DRS, Inc. SEC Filings

DRS NASDAQ

Welcome to our dedicated page for Leonardo DRS SEC filings (Ticker: DRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Leonardo DRS, Inc. (Nasdaq: DRS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Leonardo DRS is a defense technology company headquartered in Arlington, Virginia, with common stock registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC under the symbol DRS.

Through this page, users can review Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s two primary segments, Advanced Sensing and Computing and Integrated Mission Systems, along with risk factors, contract information and financial results. Form 8-K current reports document material events such as leadership transitions, board changes, earnings releases and other significant corporate developments, including updates to executive employment agreements and conference call announcements.

Investors interested in ownership and governance details can also look for proxy statements and related filings that discuss board composition and committee responsibilities. In addition, Form 4 insider transaction reports, when available, show purchases and sales of DRS common stock by directors, officers and other insiders.

Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand segment performance, major contracts in areas like advanced sensing, network computing, force protection, and electric power and propulsion, and notable changes in leadership or governance. Real-time updates from EDGAR ensure that new Leonardo DRS filings, including earnings-related 8-Ks and other disclosures, are added as they become available, giving users a structured view of the company’s regulatory history and ongoing reporting obligations.

Rhea-AI Summary

Leonardo DRS, Inc. executive Mark Dorfman, EVP, General Counsel and Secretary, sold 10,014 shares of common stock in an open-market transaction. The sale occurred at a price of $45.27 per share. After this transaction, he directly holds 17,666 shares of Leonardo DRS common stock.

According to a footnote, this sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Dorfman on June 13, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DRS affiliate Michael Dippold filed a Form 144 to sell 16,330 shares of Common Stock, identified as securities from a restricted stock vesting event. The filing lists a reported aggregate market value of $739,259.10 and an outstanding share count of 265,846,193 shares as of 03/16/2026.

The notice also records 10,588 shares sold on 01/05/2026 for $391,756.00, shown under "Securities Sold During The Past 3 Months."

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

DRS reported a proposed sale of Common Stock following a restricted stock vesting. The filing lists 10,014 shares tied to a restricted stock vesting event dated 03/15/2025. The filing also discloses that Mark Dorfman sold 7,680 shares on 01/05/2026 for $284,160.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Leonardo DRS, Inc. reported board changes tied to its proxy agreement with its majority stockholder and U.S. government security requirements. David W. Carey will retire from the Board at the end of his proxy holder term on March 31, 2026, with no disagreements cited regarding the company’s operations, policies, or practices.

The Defense Counterintelligence Security Agency approved the appointment of Reuben Jeffery III as a Class C proxy holder director, with his Board term running from April 1, 2026 through March 31, 2029. He will serve on the Audit, Nominating and Corporate Governance, and Government Security Committees and receive the standard non-employee director compensation.

The filing also notes that Dr. Louis Brothers’ term as a proxy holder director has been extended, with reappointment effective April 1, 2026 and continuing through March 31, 2029. These moves maintain the Board’s proxy holder structure under the amended and restated proxy agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
current report
-
Rhea-AI Summary

Leonardo DRS, Inc. director Casey George reported an open-market sale of 1,500 shares of common stock on March 4, 2026, at a price of $45.135 per share. After this transaction, George directly holds 28,820 shares of Leonardo DRS common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Leonardo DRS, Inc. senior vice president and controller Pamela Morrow reported an open-market sale of 12,000 shares of common stock at a weighted average price of $45.20 per share. After this transaction, she holds 6,494 shares of Leonardo DRS common stock directly.

The filing notes that the shares were sold in multiple trades within a price range of $45.15 to $45.225, and the reporting person has offered to provide full trade-level details upon request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Fidelity Brokerage Services LLC filed a Rule 144 notice to sell 12,000 common shares on 03/03/2026. The sale is listed through Fidelity Brokerage Services at 900 Salem Street, Smithfield, RI. The filing lists restricted stock vesting lots of 2,117 (03/15/2023), 2,196 (03/15/2024), 2,277 (04/04/2024), and 5,410 (11/29/2024).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
other
-
Rhea-AI Summary

Leonardo DRS, Inc. files its Annual Report describing a mid-sized defense technology business focused on U.S. national security customers and allied forces. The company operates through two segments: Advanced Sensing and Computing, and Integrated Mission Systems, supplying sensing, network computing and naval electric power and propulsion solutions.

About 80% of 2025 revenue came directly or indirectly from U.S. government contracts, heavily concentrated in the Department of War, making federal defense budgets and shutdowns critical to its outlook. Revenue is largely from fixed-price work, with 2025 sales of $3,205 million on firm-fixed price contracts and $443 million on flexibly priced contracts, which exposes the business to cost overrun and inflation risk.

The company reports funded backlog of $4,643 million as of December 31, 2025 and emphasizes long-term Navy shipbuilding and ground systems positions. It highlights extensive regulatory, security clearance, FOCI mitigation and export-control obligations, and details numerous risk factors ranging from government funding changes and audits to supply chain disruptions, cybersecurity, labor, environmental and governance constraints under its proxy agreement with the Department of War.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Summary

Leonardo DRS reported another year of solid growth for 2025, with fourth-quarter revenue of $1.06 billion (up 8%) and full-year revenue of $3.648 billion (up 13%). Full-year net earnings reached $278 million, with diluted EPS of $1.03 and Adjusted Diluted EPS of $1.15.

Adjusted EBITDA was $158 million in Q4 and $453 million for the year, both up 7% and 13% respectively, helped by a $100 million, 10‑year quantum laser IP license (net present value $73 million) and partly offset by concluding a legacy foreign ground surveillance program (reducing revenue by $67 million). Bookings were $4.245 billion with a book‑to‑bill of 1.2x, and backlog increased to $8.731 billion. Free cash flow was $227 million, supporting $96 million of dividends and $35 million of share repurchases. For 2026, the company guides revenue to $3.85–$3.95 billion, Adjusted EBITDA to $505–$525 million, and Adjusted Diluted EPS to $1.20–$1.26.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.89%
Tags
current report

FAQ

How many Leonardo DRS (DRS) SEC filings are available on StockTitan?

StockTitan tracks 51 SEC filings for Leonardo DRS (DRS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Leonardo DRS (DRS)?

The most recent SEC filing for Leonardo DRS (DRS) was filed on March 17, 2026.